Cargando…

Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer

Introduction: Focal adhesion kinase (FAK) plays a crucial role in cancer development and progression. FAK is overexpressed and/or activated and associated with poor prognosis in various malignancies. However, in lung cancer, activated FAK expression and its prognostic value are unknown. Methods: FAK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aboubakar Nana, Frank, Hoton, Delphine, Ambroise, Jérôme, Lecocq, Marylène, Vanderputten, Marie, Sibille, Yves, Vanaudenaerde, Bart, Pilette, Charles, Bouzin, Caroline, Ocak, Sebahat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827365/ https://www.ncbi.nlm.nih.gov/pubmed/31658694 http://dx.doi.org/10.3390/cancers11101526

Ejemplares similares

Restin protein expression in non‐small cell lung cancer
por: Nana, Frank Aboubakar, et al.
Publicado: (2023)

Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target
por: Aboubakar Nana, Frank, et al.
Publicado: (2019)

Targeting BRAF Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small-Cell Lung Cancer
por: Aboubakar Nana, Frank, et al.
Publicado: (2021)

Lung immunoglobulin A immunity dysregulation in cystic fibrosis
por: Collin, Amandine M., et al.
Publicado: (2020)

Altered generation of ciliated cells in chronic obstructive pulmonary disease
por: Gohy, Sophie, et al.
Publicado: (2019)

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome
por: Gerard, Ludovic, et al.
Publicado: (2021)

Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease
por: Carlier, François M., et al.
Publicado: (2020)

Bleomycin‐induced lung injury: Revisiting an old tool to model group III PH associated with pulmonary fibrosis
por: Santos‐Ribeiro, Diana, et al.
Publicado: (2023)

Expression of pY397 FAK promotes the development of non-small cell lung cancer
por: WANG, BAICHUN, et al.
Publicado: (2016)

PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer
por: Constanzo, Jerfiz D., et al.
Publicado: (2016)

ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling
por: Shan, Yuemei, et al.
Publicado: (2017)

β-elemene inhibits non-small cell lung cancer cell migration and invasion by inactivating the FAK-Src pathway
por: Zhang, Hongbo, et al.
Publicado: (2021)

FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells
por: Chuang, Hsiang-Hao, et al.
Publicado: (2022)

P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer
por: Li, Jingduo, et al.
Publicado: (2022)

Expression of the epithelial polymeric immunoglobulin receptor is decreased in allergic rhinitis and eosinophilic rhinosinusitis
por: Hupin, Cloé, et al.
Publicado: (2013)

The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study
por: Verocq, Camille, et al.
Publicado: (2020)

Recent advances in the management of non-small cell lung cancer
por: Shojaee, Samira, et al.
Publicado: (2017)

Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
por: Mahiat, Cédric, et al.
Publicado: (2023)

Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
por: Liu, Aibin, et al.
Publicado: (2021)

Cycloartocarpin Inhibits Migration through the Suppression of Epithelial-to-Mesenchymal Transition and FAK/AKT Signaling in Non-Small-Cell Lung Cancer Cells
por: Tungsukruthai, Sucharat, et al.
Publicado: (2022)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature
por: De Smedt, Fabian, et al.
Publicado: (2022)

Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway
por: Zhang, Xiupeng, et al.
Publicado: (2017)

Small cell lung cancer.
por: Leonard, R. C.
Publicado: (1989)

Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway
por: Xu, Linhao, et al.
Publicado: (2020)

ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN/PI3K/FAK pathway
por: Hu, Changpeng, et al.
Publicado: (2019)

Targeted therapies in non-small cell lung cancer: present and future
por: McLaughlin, Jessica, et al.
Publicado: (2023)

CPNE3 promotes migration and invasion in non-small cell lung cancer by interacting with RACK1 via FAK signaling activation
por: Lin, Hechun, et al.
Publicado: (2018)

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
por: Rice, Shawn J., et al.
Publicado: (2021)

Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives
por: Césaire, Mathieu, et al.
Publicado: (2022)

Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
por: Rath, Barbara, et al.
Publicado: (2020)

Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
por: Fang, Douglas D., et al.
Publicado: (2022)

FTO facilitates cancer metastasis by modifying the m(6)A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer
por: Gao, Lirong, et al.
Publicado: (2023)

Markers of small cell lung cancer
por: Taneja, Tarvinder K, et al.
Publicado: (2004)

MET and Small-Cell Lung Cancer
por: Gelsomino, Francesco, et al.
Publicado: (2014)

Immunotherapy in Small Cell Lung Cancer
por: Esposito, Giovanna, et al.
Publicado: (2020)

Lurbinectedin for small cell lung cancer
Publicado: (2021)

Surgery in Small-Cell Lung Cancer
por: Martucci, Nicola, et al.
Publicado: (2021)

Lurbinectedin in small cell lung cancer
por: Manzo, Anna, et al.
Publicado: (2022)

Targeting netrin‐3 in small cell lung cancer and neuroblastoma
por: Jiang, Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_98dams1j5tsrcrthqc7hhm27rg